The Olidata group and Fondazione Policlinico Universitario Campus Bio-Medico have embarked on a path of collaboration for the development of predictive technology (AI) for early detection and screening of lung cancer.

The Olidata Group, which has long been engaged in research in the field of artificial intelligence, following a path started in January 2022, has realized the AILANTON Project, thanks to the integrated working group composed of resources from Sferanet and specialized physicians from the Policlinico Universitario Campus Bio-Medico Foundation.

The Project, with all its components, is unique in Italy for both the integrated Structured Referral system and the AI System used, a model not present on the ICT market to date. From the first stages of analysis, the accuracy rate in nodule recognition is above 90 percent with prospects for growth depending on the massive data analysis capacity that the Olidata software proposes to make efficient in the next project step, with the aim of speeding up the work of radiology physicians.

Read more at
https://olidata.com/comunicati-finanziari-2020-oggi/